stars 1 stars 2 stars 3

BCN Peptides is a privately held company focused on the cGMP Industrial Manufacture of Bioactive Peptides for Pharmaceutical and Veterinary applications. We concentrate in the following activities: GMP Bulk Generic Peptides and Custom Synthesis of proprietary API Peptides. BCN Peptides has an excellent GMP compliance track record: FDA Approved, EDQM Approved and it holds multiple CEPs from European Pharmacopoeia. We manufacture multi-kilo batches of GMP Peptide using SPPS technology: from the R&D, through batches for the Clinical Trials, up to Bulk Commercial Quantities.

BCN Peptides Questions

The BCN Peptides annual revenue was $7 million in 2026.

Berta Ponsati is the CEO of BCN Peptides.

59 people are employed at BCN Peptides.

The NAICS codes for BCN Peptides are [3254, 325, 32, 32541].

The SIC codes for BCN Peptides are [28, 283].

Top BCN Peptides Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users